VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Jan. 17, 2007) - Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced further expansion of its near infrared spectroscopy ("NIRS") clinical development program to include applications in acute Compartment Syndrome ("CS"). The Company also filed a patent application extending its intellectual property portfolio to encompass CS applications and released the results of a preliminary CS clinical study completed at Foothills Medical Center in Calgary, Alberta.
